PAM
MAIA icon

PVG Asset Management’s MAIA Biotechnology MAIA Stock Holding History

PVG Asset Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2K Hold
34,135
– – 0.03% 130
2026
Q1 		$46.4K Buy
+34,135
New +$62.9K 0.03% 123

Other funds holding MAIA

LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
CAG
Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PVG Asset Management's MAIA Position: Q2 2026 in Review

PVG Asset Management held its MAIA Biotechnology (MAIA) position steady in Q2 2026 at 34,135 shares worth $49.2K. The position accounts for 0.03% of the portfolio, ranked #130.

PVG Asset Management first reported a position in MAIA in Q1 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • PVG Asset Management held 34,135 shares of MAIA Biotechnology worth $49.2K as of Q2 2026.
  • PVG Asset Management left its MAIA Biotechnology share count unchanged in Q2 2026.
  • MAIA Biotechnology made up 0.03% of PVG Asset Management's portfolio in Q2 2026, its #130 holding.
  • PVG Asset Management first reported a position in MAIA Biotechnology in Q1 2026 and has held it in 2 quarters since.
  • 5 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on PVG Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.